Pancreaticoduodenectomy for borderline resectable pancreatic head cancer with a modified artery-first approach technique

Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):215-221. doi: 10.1016/s1499-3872(16)60171-6.

Abstract

Background: The treatment of borderline resectable pancreatic head cancer (BRPHC) is still controversial and challenging. The artery-first approaches are described to be the important options for the early determination. Whether these approaches can achieve an increase R0 rate, better bleeding control and increasing long-term survival for BRPHC are still controversial. We compared a previously reported technique, a modified artery-first approach (MAFA), with conventional techniques for the surgical treatment of BRPHC.

Methods: A total of 117 patients with BRPHC undergone pancreaticoduodenectomy (PD) from January 2013 to June 2015 were included. They were divided into an MAFA group (n=78) and a conventional-technique group (n=39). Background characteristics, operative data and complications were compared between the two groups.

Results: Mean operation time was significantly shorter in the MAFA group than that in the conventional-technique group (313 vs 384 min; P=0.014); mean volume of intraoperative blood loss was significantly lower in the MAFA group than that in the conventional-technique group (534 vs 756 mL; P=0.043); and mean rate of venous resection was significantly higher in the conventional-technique group than that in the MAFA group (61.5% vs 35.9%; P=0.014). Pathologic data, early mortality and morbidity were not different significantly between the two groups.

Conclusions: MAFA is safe, simple, less time-consuming, less intraoperative blood loss and less venous resection, and therefore, may become a standard surgical approach to PD for BRPHC with the superior mesenteric vein-portal vein involvement but without superior mesenteric artery invasion.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Blood Loss, Surgical
  • Female
  • Humans
  • Male
  • Mesenteric Artery, Superior / surgery*
  • Mesenteric Veins / pathology
  • Mesenteric Veins / surgery
  • Middle Aged
  • Neoplasm Invasiveness
  • Operative Time
  • Pancreatic Neoplasms / classification
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy / adverse effects
  • Pancreaticoduodenectomy / methods*
  • Pancreaticoduodenectomy / mortality
  • Portal Vein / pathology
  • Portal Vein / surgery
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome